In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world. Read More
CSL Facility on the Front Line of Flu Fight
The Kankakee, IL facility and its flu vaccine preparations were the feature of a recent Chicago news program.
Seqirus is first-to-market with shipment of seasonal influenza vaccines to the US for the 2016-2017 season
The Seqirus portfolio for this season will ...
Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT™ (Influenza Vaccine) for people four years of age and older
This is the first four-strain, cell ...
Seqirus Honored with National Award for Outstanding Efforts in Influenza Prevention
The accolade recognizes Seqirus’ creative and ...
Search Career Opportunities
At Seqirus, each employee has the opportunity to play a role in improving people's health.